Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Polish Forum for Prevention Guidelines on Prophylactic Pharmacotherapy: update 2017.

Podolec P, Filipiak KJ, Undas A, Pająk A, Godycki-Ćwirko M, Drygas W, Zdrojewski T, Jankowski P, Podolec J, Komar M, Sarnecka A, Kozek E, Czarnecka D, Małecki M, Nowicka G, Członkowska A, Niewada M, Stańczyk J, Windak A, Guzik T, Kopeć G.

Kardiol Pol. 2017;75(5):508-511. doi: 10.5603/KP.2017.0087. No abstract available.

PMID:
28530029
2.

Disease Course of Lower Respiratory Tract Infection With a Bacterial Cause.

Teepe J, Broekhuizen BD, Loens K, Lammens C, Ieven M, Goossens H, Little P, Butler CC, Coenen S, Godycki-Cwirko M, Verheij T; GRACE Consortium..

Ann Fam Med. 2016 Nov;14(6):534-539. doi: 10.1370/afm.1974.

3.

How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.

Laue J, Melbye H, Halvorsen PA, Andreeva EA, Godycki-Cwirko M, Wollny A, Francis NA, Spigt M, Kung K, Risør MB.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 8;11:3109-3119. eCollection 2016.

4.

Predicting the presence of bacterial pathogens in the airways of primary care patients with acute cough.

Teepe J, Broekhuizen BD, Loens K, Lammens C, Ieven M, Goossens H, Little P, Butler CC, Coenen S, Godycki-Cwirko M, Verheij TJ; GRACE Consortium..

CMAJ. 2016 Oct 24. pii: cmaj.151364. [Epub ahead of print]

5.

Family Practitioners' Advice about Taking Time Off Work for Lower Respiratory Tract Infections: A Prospective Study in Twelve European Primary Care Networks.

Godycki-Cwirko M, Nocun M, Butler CC, Little P, Verheij T, Hood K, Fleten N, Kowalczyk A, Melbye H.

PLoS One. 2016 Oct 19;11(10):e0164779. doi: 10.1371/journal.pone.0164779. eCollection 2016.

6.

Process evaluation of five tailored programs to improve the implementation of evidence-based recommendations for chronic conditions in primary care.

Jäger C, Steinhäuser J, Freund T, Baker R, Agarwal S, Godycki-Cwirko M, Kowalczyk A, Aakhus E, Granlund I, van Lieshout J, Szecsenyi J, Wensing M.

Implement Sci. 2016 Sep 13;11(1):123. doi: 10.1186/s13012-016-0473-8.

7.

Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study.

Malhotra-Kumar S, Van Heirstraeten L, Coenen S, Lammens C, Adriaenssens N, Kowalczyk A, Godycki-Cwirko M, Bielicka Z, Hupkova H, Lannering C, Mölstad S, Fernandez-Vandellos P, Torres A, Parizel M, Ieven M, Butler CC, Verheij T, Little P, Goossens H; GRACE study group..

J Antimicrob Chemother. 2016 Nov;71(11):3258-3267. Epub 2016 Jun 26.

PMID:
27353466
8.

Discrepancies between qualitative and quantitative evaluation of randomised controlled trial results: achieving clarity through mixed methods triangulation.

Tonkin-Crine S, Anthierens S, Hood K, Yardley L, Cals JW, Francis NA, Coenen S, van der Velden AW, Godycki-Cwirko M, Llor C, Butler CC, Verheij TJ, Goossens H, Little P; GRACE INTRO/CHAMP consortium..

Implement Sci. 2016 May 12;11:66. doi: 10.1186/s13012-016-0436-0.

9.

Patient safety initiatives in Central and Eastern Europe: A mixed methods approach by the LINNEAUS collaboration on patient safety in primary care.

Godycki-Cwirko M, Esmail A, Dovey S, Wensing M, Parker D, Kowalczyk A, Błaszczyk H, Kosiek K.

Eur J Gen Pract. 2015 Sep;21 Suppl:62-8. doi: 10.3109/13814788.2015.1043727. Review.

10.

Developing a patient safety incident classification system for primary care. A literature review and Delphi-survey by the LINNEAUS collaboration on patient safety in primary care.

Klemp K, Dovey S, Valderas JM, Rohe J, Godycki-Cwirko M, Elliott P, Beyer M, Gerlach FM, Hoffmann B.

Eur J Gen Pract. 2015 Sep;21 Suppl:35-8. doi: 10.3109/13814788.2015.1043723. Review.

11.

Developing a research agenda for patient safety in primary care. Background, aims and output of the LINNEAUS collaboration on patient safety in primary care.

Esmail A, Valderas JM, Verstappen W, Godycki-Cwirko M, Wensing M.

Eur J Gen Pract. 2015 Sep;21 Suppl:3-7. doi: 10.3109/13814788.2015.1043122.

12.

Assessing family medicine trainees--what can we learn from the European neighbours?

Flum E, Maagaard R, Godycki-Cwirko M, Scarborough N, Scherpbier N, Ledig T, Roos M, Steinhäuser J.

GMS Z Med Ausbild. 2015 May 13;32(2):Doc21. doi: 10.3205/zma000963. eCollection 2015.

13.

Tailored interventions to address determinants of practice.

Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N, Wensing M, Fiander M, Eccles MP, Godycki-Cwirko M, van Lieshout J, Jäger C.

Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470. doi: 10.1002/14651858.CD005470.pub3. Review.

PMID:
25923419
14.

Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota.

Vervoort J, Xavier BB, Stewardson A, Coenen S, Godycki-Cwirko M, Adriaenssens N, Kowalczyk A, Lammens C, Harbarth S, Goossens H, Malhotra-Kumar S.

J Antimicrob Chemother. 2015 Jul;70(7):1989-92. doi: 10.1093/jac/dkv062. Epub 2015 Mar 12.

PMID:
25766736
15.

Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.

Stewardson AJ, Gaïa N, François P, Malhotra-Kumar S, Delémont C, Martinez de Tejada B, Schrenzel J, Harbarth S, Lazarevic V; SATURN WP1 and WP3 Study Groups..

Clin Microbiol Infect. 2015 Apr;21(4):344.e1-11. doi: 10.1016/j.cmi.2014.11.016. Epub 2014 Nov 25.

16.

Stakeholders' contributions to tailored implementation programs: an observational study of group interview methods.

Huntink E, van Lieshout J, Aakhus E, Baker R, Flottorp S, Godycki-Cwirko M, Jäger C, Kowalczyk A, Szecsenyi J, Wensing M.

Implement Sci. 2014 Dec 6;9:185. doi: 10.1186/s13012-014-0185-x.

17.

Illness perception and related behaviour in lower respiratory tract infections—a European study.

Hordijk PM, Broekhuizen BD, Butler CC, Coenen S, Godycki-Cwirko M, Goossens H, Hood K, Smith R, van Vugt SF, Little P, Verheij TJ; GRACE Project Group..

Fam Pract. 2015 Apr;32(2):152-8. doi: 10.1093/fampra/cmu075. Epub 2014 Nov 18.

18.

Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections.

Anthierens S, Tonkin-Crine S, Cals JW, Coenen S, Yardley L, Brookes-Howell L, Fernandez-Vandellos P, Krawczyk J, Godycki-Cwirko M, Llor C, Butler CC, Verheij T, Goossens H, Little P, Francis NA; GRACE/CHAMP INTRO team..

J Gen Intern Med. 2015 Apr;30(4):408-16. doi: 10.1007/s11606-014-3076-6. Epub 2014 Nov 6.

19.

Public beliefs on antibiotics and symptoms of respiratory tract infections among rural and urban population in Poland: a questionnaire study.

Godycki-Cwirko M, Cals JW, Francis N, Verheij T, Butler CC, Goossens H, Zakowska I, Panasiuk L.

PLoS One. 2014 Oct 2;9(10):e109248. doi: 10.1371/journal.pone.0109248. eCollection 2014.

20.

An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.

Vervoort J, Xavier BB, Stewardson A, Coenen S, Godycki-Cwirko M, Adriaenssens N, Kowalczyk A, Lammens C, Harbarth S, Goossens H, Malhotra-Kumar S.

Antimicrob Agents Chemother. 2014 Dec;58(12):7225-33. doi: 10.1128/AAC.03952-14. Epub 2014 Sep 22.

Supplemental Content

Loading ...
Support Center